Mutation Spectrum of Six Genes in Chinese Phenylketonuria Patients Obtained through Next-Generation Sequencing

<div><p>Background</p><p>The identification of gene variants plays an important role in the diagnosis of genetic diseases.</p><p>Methodology/Principal Findings</p><p>To develop a rapid method for the diagnosis of phenylketonuria (PKU) and tetrahydrobiopterin (BH4) deficiency, we designed a multiplex, PCR-based primer panel to amplify all the exons and flanking regions (50 bp average) of six PKU-associated genes (<i>PAH, PTS, GCH1, QDPR, PCBD1</i> and <i>GFRP</i>). The Ion Torrent Personal Genome Machine (PGM) System was used to detect mutations in all the exons of these six genes. We tested 93 DNA samples from blood specimens from 35 patients and their parents (32 families) and 26 healthy adults. Using strict bioinformatic criteria, this sequencing data provided, on average, 99.14% coverage of the 39 exons at more than 70-fold mean depth of coverage. We found 23 previously documented variants in the <i>PAH</i> gene and six novel mutations in the <i>PAH</i> and <i>PTS</i> genes. A detailed analysis of the mutation spectrum of these patients is described in this study.</p><p>Conclusions/Significance</p><p>These results were confirmed by Sanger sequencing. In conclusion, benchtop next-generation sequencing technology can be used to detect mutations in monogenic diseases and can detect both point mutations and indels with high sensitivity, fidelity and throughput at a lower cost than conventional methods in clinical applications.</p>